Skip to main content

RxOutlook®

The latest pipeline drug information, trend news, upcoming drug launches and emerging therapies in today’s pharmaceutical market.

1st Quarter 2025

Key topics in this quarter’s edition include:

  • Amvuttra (vutrisiran) for cardiomyopathy of transthyretin-mediated amyloidosis
  • Sebetralstat for hereditary angioedema
  • Nipocalimab for generalized myasthenia gravis

Download PDF

Rx navigation